NO993161L - Cyklooksygenaseinhibitor - Google Patents

Cyklooksygenaseinhibitor

Info

Publication number
NO993161L
NO993161L NO993161A NO993161A NO993161L NO 993161 L NO993161 L NO 993161L NO 993161 A NO993161 A NO 993161A NO 993161 A NO993161 A NO 993161A NO 993161 L NO993161 L NO 993161L
Authority
NO
Norway
Prior art keywords
cyclooxygenase inhibitors
cyclooxygenase
inhibitors
Prior art date
Application number
NO993161A
Other languages
English (en)
Norwegian (no)
Other versions
NO993161D0 (no
Inventor
Zyunji Tanaka
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of NO993161D0 publication Critical patent/NO993161D0/no
Publication of NO993161L publication Critical patent/NO993161L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00Compounds containing selenium
    • C07C391/02Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO993161A 1998-07-01 1999-06-25 Cyklooksygenaseinhibitor NO993161L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10186234A JP2000016935A (ja) 1998-07-01 1998-07-01 シクロオキシゲナーゼ阻害剤

Publications (2)

Publication Number Publication Date
NO993161D0 NO993161D0 (no) 1999-06-25
NO993161L true NO993161L (no) 2000-01-03

Family

ID=16184711

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993161A NO993161L (no) 1998-07-01 1999-06-25 Cyklooksygenaseinhibitor

Country Status (11)

Country Link
US (1) US6495517B2 (ja)
EP (1) EP0972515A3 (ja)
JP (1) JP2000016935A (ja)
CN (1) CN1243749A (ja)
AU (1) AU765476B2 (ja)
CA (1) CA2276984A1 (ja)
DE (1) DE19915954A1 (ja)
NO (1) NO993161L (ja)
TR (1) TR199901535A2 (ja)
WO (1) WO2000001380A1 (ja)
ZA (1) ZA994289B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3457300A (en) 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
CN1463972A (zh) * 2002-06-19 2003-12-31 中国医学科学院药物研究所 新的n-取代吡啶基苯并异硒唑酮化合物及其制法和其药物组合物与用途
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN109627198B (zh) * 2019-02-01 2020-11-10 河南科技大学 一种2-丙酮基硒基苯甲酰胺类化合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027075A1 (de) * 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3027074A1 (de) * 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolon enthaltende pharmazeutische praeparate und ihre verwendung
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3568775D1 (en) * 1984-06-22 1989-04-20 Nattermann A & Cie S-(carbamoyl-phenylselenyl) derivatives of glutathion and of amino mercaptocarboxylic acids, process for their preparation and pharmaceutical preparations containing them
DE3663139D1 (en) * 1985-04-12 1989-06-08 Nattermann A & Cie Diseleno-bis-benzamides of primary and secondary amines, processes for their production and pharmaceutical preparations containing them
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JP2710633B2 (ja) * 1987-08-28 1998-02-10 第一製薬株式会社 心臓疾患治療剤
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤
DE19506669A1 (de) * 1995-02-25 1996-08-29 Nattermann A & Cie Lipoxygenasehemmer
IL124006A (en) * 1996-01-26 2004-07-25 Nattermann A & Cie Therapeutic compositions for the treatment of bronchial asthma containing 2-phenyl-1, 2-benzoisoselenazole-3 (2h)-one
ES2177849T3 (es) * 1996-08-27 2002-12-16 Nattermann A & Cie Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.

Also Published As

Publication number Publication date
CA2276984A1 (en) 2000-01-01
NO993161D0 (no) 1999-06-25
ZA994289B (en) 2001-01-02
TR199901535A3 (tr) 2000-03-21
DE19915954A1 (de) 2000-01-05
TR199901535A2 (en) 2000-03-21
AU765476B2 (en) 2003-09-18
EP0972515A2 (de) 2000-01-19
CN1243749A (zh) 2000-02-09
US20010027176A1 (en) 2001-10-04
AU3681899A (en) 2000-01-20
EP0972515A3 (de) 2000-01-26
JP2000016935A (ja) 2000-01-18
WO2000001380A1 (de) 2000-01-13
US6495517B2 (en) 2002-12-17

Similar Documents

Publication Publication Date Title
ATE341990T1 (de) Sigmidoskop
DE59901560D1 (de) Retrograder tibianagel
NO992430D0 (no) R°rkobling
NO990113D0 (no) Flerskrog-fart°y
NO992198D0 (no) R°rledningspigg
ATE262513T1 (de) Benzoylpyridazine
DE59903966D1 (de) Exzenterzahnradgetriebe
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
ID28624A (id) Turunan 2-fenilpiran-4-on
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
DE69903319D1 (de) Fkbp inhibitoren
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59807217D1 (de) Nadellager
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
ID23196A (id) Gandaran untuk lampuflouresen
DE59808995D1 (de) Endomikroskopsystem
DE19842103B4 (de) Stanznietzuführung
NO993161D0 (no) Cyklooksygenaseinhibitor
DE59903616D1 (de) Rollenwicklerwalze
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DE59901263D1 (de) Einzelplatz-sortierer
DE59903771D1 (de) Hydro-transformator
ATA126298A (de) Verpuffungsklappe
DE29819079U1 (de) Kombuchalyophilisat
DE29807387U1 (de) Schließe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application